Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pulmonary Device Companies Take It To The Streets - In Europe

This article was originally published in Start Up

Executive Summary

For the past decade, venture capitalists have invested in companies that are developing new technologies to treat late-stage chronic obstructive pulmonary disorders.Despite hundreds of millions in venture capital dollars, the companies have made little progress in bringing these products to market in the US. But this band of start-ups is taking the fight to the streets - of Europe.
Advertisement

Related Content

Device Companies Look West, East, Anyplace But US
Rox Gets Blood Pumping in COPD
Asthmatx Acquisition By Boston Scientific Is Source of Many Happy Returns
Asthmatx Following the Leaders In Defining Alair Sales Strategy
Asthmatx Positive Panel Outcome Good Sign for Pulmonology Companies
Emphysema Devices Search for Breathing Room
FDA Panel Vote on Valve Disappoints Emphasys
Emphysema: Elusive Target for Device Companies
Asthmatx Breathes Easier
Emphasys Medical Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel